132 related articles for article (PubMed ID: 35333485)
21. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
22. NRP1 regulates radiation-induced EMT via TGF-β/Smad signaling in lung adenocarcinoma cells.
Chen Z; Gao H; Dong Z; Shen Y; Wang Z; Wei W; Yi J; Wang R; Wu N; Jin S
Int J Radiat Biol; 2020 Oct; 96(10):1281-1295. PubMed ID: 32659143
[TBL] [Abstract][Full Text] [Related]
23. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.
Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
25. Tannic acid attenuates TGF-β1-induced epithelial-to-mesenchymal transition by effectively intervening TGF-β signaling in lung epithelial cells.
Pattarayan D; Sivanantham A; Krishnaswami V; Loganathan L; Palanichamy R; Natesan S; Muthusamy K; Rajasekaran S
J Cell Physiol; 2018 Mar; 233(3):2513-2525. PubMed ID: 28771711
[TBL] [Abstract][Full Text] [Related]
26. Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway.
Ihara H; Mitsuishi Y; Kato M; Takahashi F; Tajima K; Hayashi T; Hidayat M; Winardi W; Wirawan A; Hayakawa D; Kanamori K; Matsumoto N; Yae T; Sato T; Sasaki S; Takamochi K; Suehara Y; Ogura D; Niwa SI; Suzuki K; Takahashi K
Respir Investig; 2020 Jul; 58(4):275-284. PubMed ID: 32359980
[TBL] [Abstract][Full Text] [Related]
27. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion.
Lim WC; Kim H; Kim YJ; Choi KC; Lee IH; Lee KH; Kim MK; Ko H
Bioorg Med Chem Lett; 2017 Aug; 27(15):3342-3348. PubMed ID: 28610976
[TBL] [Abstract][Full Text] [Related]
28. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
Da C; Liu Y; Zhan Y; Liu K; Wang R
Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
[TBL] [Abstract][Full Text] [Related]
29. Aspirin-triggered resolvin D1 inhibits TGF-β1-induced EMT through the inhibition of the mTOR pathway by reducing the expression of PKM2 and is closely linked to oxidative stress.
Liu Y; Yuan X; Li W; Cao Q; Shu Y
Int J Mol Med; 2016 Oct; 38(4):1235-42. PubMed ID: 27573422
[TBL] [Abstract][Full Text] [Related]
30. CK2 inhibitor CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells.
Kim J; Hwan Kim S
PLoS One; 2013; 8(9):e74342. PubMed ID: 24023938
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor β1 promotes fibroblast-like synoviocytes migration and invasion via TGF-β1/Smad signaling in rheumatoid arthritis.
Zhu D; Zhao J; Lou A; Huang Q; OuYang Q; Zhu J; Fan M; He Y; Ren H; Yang M
Mol Cell Biochem; 2019 Sep; 459(1-2):141-150. PubMed ID: 31297660
[TBL] [Abstract][Full Text] [Related]
32. SPARC acts as a mediator of TGF-β1 in promoting epithelial-to-mesenchymal transition in A549 and H1299 lung cancer cells.
Sun W; Feng J; Yi Q; Xu X; Chen Y; Tang L
Biofactors; 2018 Sep; 44(5):453-464. PubMed ID: 30346081
[TBL] [Abstract][Full Text] [Related]
33. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
34. Glycyrrhizin suppresses epithelial-mesenchymal transition by inhibiting high-mobility group box1 via the TGF-
Gui Y; Sun J; You W; Wei Y; Tian H; Jiang S
PeerJ; 2020; 8():e8514. PubMed ID: 32117622
[TBL] [Abstract][Full Text] [Related]
35. Involvement of epithelial-mesenchymal transition afforded by activation of LOX-1/ TGF-β1/KLF6 signaling pathway in diabetic pulmonary fibrosis.
Zou XZ; Gong ZC; Liu T; He F; Zhu TT; Li D; Zhang WF; Jiang JL; Hu CP
Pulm Pharmacol Ther; 2017 Jun; 44():70-77. PubMed ID: 28315789
[TBL] [Abstract][Full Text] [Related]
36. Ginsenosides Rk1 and Rg5 inhibit transforming growth factor-β1-induced epithelial-mesenchymal transition and suppress migration, invasion, anoikis resistance, and development of stem-like features in lung cancer.
Kim H; Choi P; Kim T; Kim Y; Song BG; Park YT; Choi SJ; Yoon CH; Lim WC; Ko H; Ham J
J Ginseng Res; 2021 Jan; 45(1):134-148. PubMed ID: 33437165
[TBL] [Abstract][Full Text] [Related]
37. TGF-β1 Induces EMT in Bovine Mammary Epithelial Cells Through the TGFβ1/Smad Signaling Pathway.
Chen Q; Yang W; Wang X; Li X; Qi S; Zhang Y; Gao MQ
Cell Physiol Biochem; 2017; 43(1):82-93. PubMed ID: 28848180
[TBL] [Abstract][Full Text] [Related]
38. Exogenous hydrogen sulfide donor NaHS alleviates nickel-induced epithelial-mesenchymal transition and the migration of A549 cells by regulating TGF-β1/Smad2/Smad3 signaling.
Ye M; Yu M; Yang D; Li J; Wang H; Chen F; Yu H; Shen T; Zhu Q; Zhou C
Ecotoxicol Environ Saf; 2020 Jun; 195():110464. PubMed ID: 32171946
[TBL] [Abstract][Full Text] [Related]
39. Nannocystin Ax, a natural elongation factor 1α inhibitor from Nannocystis sp., suppresses epithelial-mesenchymal transition, adhesion and migration in lung cancer cells.
Sun C; Liu R; Xia M; Hou Y; Wang X; Lu JJ; Liu B; Chen X
Toxicol Appl Pharmacol; 2021 Jun; 420():115535. PubMed ID: 33848516
[TBL] [Abstract][Full Text] [Related]
40. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
